Tenofovir Douche

DRUG3 trials

Sponsors

Johns Hopkins University, University of Pennsylvania

Conditions

HIV PreventionHIV/AIDS

Phase 1

Tenofovir Rectal Douche to Prevent HIV Transmission

CompletedNCT04016233

Johns Hopkins UniversityHIV/AIDS, HIV Prevention

Start: 2020-01-10End: 2021-04-27Updated: 2021-06-09

Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse

CompletedNCT04195776

Johns Hopkins UniversityHIV/AIDS, HIV Prevention

Start: 2021-06-01End: 2022-12-31Updated: 2023-01-17

Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM)

CompletedNCT04686279

University of PennsylvaniaHIV/AIDS, HIV Prevention

Start: 2021-04-01End: 2022-11-30Updated: 2023-10-30

Related Papers

Safety, Pharmacokinetics, and Acceptability of a Tenofovir Rectal Microbicide Douche Among Young Men Who Have Sex With Men: The DREAM ATN Study (ATN 163).

2025-10-01

Assessing the Acceptability of a Tenofovir-Based Rectal Microbicide Douche among Young Men who Have Sex with Men: Results from ATN-DREAM (ATN 163)

AIDS and Behavior2025-05-292 citations

Anal Sex and Tenofovir Douche Sequence Impacts Colorectal Distribution of HIV Surrogate and Douche: DREAM-02

The Journal of Infectious Diseases2025-05-29